MENU
VINC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Vincerx Pharma (VINC) Ownership - Who owns Vincerx Pharma?
Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer... Show more
Profile
Industry
N/A
Address
260 Sheridan Avenue
Phone
+1 650 800-6676
Employees
42
Web
https://www.vincerx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.29M
P/E Ratio
N/A
Total Cash
80.86M
Projected Growth
N/A
Total Debt
1.64M
Revenue
N/A
Risk (Beta)
1.51
Dividend Yield
N/A
Total Cash/Share
36.10
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
VINC
Capitalization
1.29M
P/E Ratio
N/A
Risk (Beta)
1.51
Dividend Yield
N/A
Total Cash
80.9M
Total Cash/Share
36.10
Total Debt
1.64M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
9.11M
P/B Ratio
0.47
Cash Flow
N/A
Earnings
-17.2
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
2.17
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-27.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-131.14
Shares Held By Institutions
1.32M
Shares Outstanding - Current
2.24M
Total Liabilities
5.84M
Total Volume MTD
N/A
Value
1
Gain YTD
-89.060
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a blank check company, which was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, and reorganization
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
260 Sheridan Avenue
Phone
+1 650 800-6676
Employees
42
Web
https://www.vincerx.com